首页 > 市场调查报告书 > 医疗设备

生技设备细胞培养

市场调查报告书

商品编码

1511363

到 2030 年原代细胞培养市场预测：按产品、细胞类型、分离方法、应用、最终用户和地区进行的全球分析

Primary Cell Culture Market Forecasts to 2030 - Global Analysis By Product (Primary Cells, Reagents and Supplements and Other Products), Cell Type (Human Cells and Animal Cells), Separation Method, Application, End User and By Geography

出版日期: 2024年07月06日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

根据 Stratistics MRC 的数据，2024 年全球原代细胞培养市场规模为 56.2 亿美元，预计预测期内复合年增长率为 15.3%，到 2030 年将达到 131.9 亿美元。

原代细胞培养是指直接从组织或生物体分离细胞并在受控条件下进行试管内培养的过程。此方法保留了细胞的大部分生理、生化和遗传特性，并提供了密切模拟体内条件的培养物。然而，原代培养细胞的寿命有限，通常具有有限的分裂次数。

根据世界卫生组织预测，全球癌症死亡人数将持续增加，到2030年将达到1,700万以上。

不断成长的製药和生物技术产业

製药和生物技术领域的成长正在推动原代细胞培养市场，刺激了对创新和可靠的细胞模型的需求。这些领域需要高品质的原代细胞来进行药物发现、开发和测试，因为与永生化细胞株相比，它们提供了更多的生理相关资料。个人化医疗和再生疗法的进步进一步增加了对特定原代细胞的需求。此外，对生技药品和生物相似药的日益关注需要使用原代细胞来评估药物功效和安全性。

有限的可用率

原代细胞培养市场的供应有限是指采购和取得原代细胞用于研究和生产的挑战。原代细胞非常稀有且昂贵，因为它们直接源自组织并且寿命有限。分离过程在技术上很困难，只能产生有限数量的活细胞。此外，捐助者的可变性、道德考虑和严格的监管要求进一步限制了其可用性。

3D 细胞培养的进展

3D 细胞培养技术的进步正在显着增强原代细胞培养市场。与传统的 2D 培养相比，这些技术透过更好地模仿体内环境，提供了更生理相关的模型。基于支架的系统、球体和类器官等创新可以实现更精确的细胞-细胞和细胞-基质相互作用。这将导致疾病建模、药物筛检和组织工程应用的改进。此外，3D 培养可支持原代细胞的生长，保留其分化状态和功能，使它们对个人化医疗和再生治疗有价值。

再现性和标准化问题

再现性和标准化是原代细胞培养市场的关键问题。直接源自组织的原代细胞表现出固有的生物变异性，导致实验结果不一致。标准化问题源自于缺乏统一的协议和品管，使得难以确保不同实验室和实验的一致性。这些挑战可能会妨碍研究结果的可靠性，影响基于细胞的检测的开发，并使监管核准复杂化。

COVID-19 的影响：

COVID-19 大流行对原代细胞培养市场产生了重大影响，主要是透过供应链中断和实验室操作延误。对 SARS-CoV-2 相关研究的需求不断增长，推动了市场成长，原代细胞培养对于研究病毒行为、开发疫苗和测试抗病毒药物至关重要。各研究所将重点转向 COVID-19 研究，加速细胞培养技术的创新和资金筹措。然而，我们对流行病相关研究的关注导致了非 COVID-19 研究的延误，影响了我们的整体研究管道和计划时间表。

预计原电池产业在预测期内将是最大的

原代细胞培养市场中原代细胞细分市场的成长归因于多种因素。对于用于药物开发和测试的更生理相关的细胞模型的需求不断增长，而原代细胞可以提供这一点，因为它们是直接从组织中提取的。该领域受益于维持细胞完整性和功能的分离技术的进步，提高了效用。此外，与永生化细胞株相比，原代细胞使研究人员能够更精确地研究复杂的细胞间相互作用和疾病机制。

酵素降解领域预计在预测期内复合年增长率最高

原代细胞培养市场中的酵素降解是在细胞培养过程中使用酵素将细胞从组织中解离或降解不必要的细胞成分的过程。该领域的成长是由于对高效、良性细胞分离和维护方法的需求不断增长而推动的。胰蛋白酶、胶原蛋白酶和分散酶等酶对于以最小的损伤实现高细胞产量至关重要，从而支持研究、药物开发和再生医学中的各种应用。酵素技术的进步，包括重组酶的开发和改进的配方，使酵素消化方法更加可靠和具体。

占比最大的领域：

由于多种因素，北美地区的原代细胞培养市场正在经历显着成长。首先，生物技术和製药领域的研发活动不断增加，推动了药物发现和药物开发对原代细胞培养技术的需求。慢性病的增加和个人化医疗的需求强调了原代细胞培养在研究疾病机制和开发标靶治疗中的重要性。此外，学术机构、研究机构和产业相关人员之间的合作透过促进知识交流为该地区的发展做出了贡献。

复合年增长率最高的地区：

由于多种因素，亚太地区的原代细胞培养市场正在经历显着成长。需求受到中国、印度、日本和韩国等国家生物技术和製药业投资增加的推动。这些国家正在扩大其研究能力和基础设施，并培育适合细胞培养技术的环境。此外，慢性病盛行率的上升推动了对药物开发高级研究的需求，进一步推动了市场的发展。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

公司简介
- 其他市场参与者的综合分析（最多 3 家公司）
- 主要企业SWOT分析（最多3家企业）
区域分割
- 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
竞争基准化分析
- 根据产品系列、地理分布和策略联盟对主要企业基准化分析

北美洲
- 美国
- 加拿大
- 墨西哥
欧洲
- 德国
- 英国
- 义大利
- 法国
- 西班牙
- 其他欧洲国家
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 纽西兰
- 韩国
- 其他亚太地区
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地区
中东/非洲
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 卡达
- 南非
- 其他中东/非洲

第十一章主要进展

合约、伙伴关係、协作和合资企业
收购和合併
新产品发布
业务扩展
其他关键策略

第十二章公司概况

American Type Culture Collection
Axol Bioscience Ltd.
BioIVT
CGT Global
Corning Incorporated
Creative Bioarray
Cyagen
Danaher
Epithelix Sarl
FUJIFILM Wako Pure Chemical Corporation
HemaCare Corporation
Lonza Bioscience
Mattek
Merck KGaA
Neuromics
PPA Research Group, Inc.
ReachBio LLC
STEMCELL Technologies
Thermo Fisher Scientific Inc.
XenoTech, LLC

简介目录图表

Product Code: SMRC26751

According to Stratistics MRC, the Global Primary Cell Culture Market is accounted for $5.62 billion in 2024 and is expected to reach $13.19 billion by 2030 growing at a CAGR of 15.3% during the forecast period. Primary cell culture refers to the process of isolating cells directly from a tissue or organism and growing them in vitro under controlled conditions. This method provides a culture that closely mimics the in vivo state of the cells, retaining most of their physiological, biochemical, and genetic characteristics. However, primary cultures have a limited lifespan and usually undergo senescence after a finite number of divisions.

According to WHO projections, the number of cancer deaths worldwide will continue to climb and will reach over 17 million by 2030.

Market Dynamics:

Driver:

Growing pharmaceutical and biotech sectors

The growing pharmaceutical and biotech sectors are driving the primary cell culture market by fueling the demand for innovative and reliable cell-based models. These sectors require high-quality primary cells for drug discovery, development, and testing, as they provide more physiologically relevant data compared to immortalized cell lines. Advances in personalized medicine and regenerative therapies further amplify the need for specific primary cells. Additionally, the increasing focus on biologics and biosimilars necessitates the use of primary cells to evaluate drug efficacy and safety.

Restraint:

Limited availability

The limited availability restraint in the Primary Cell Culture Market refers to the challenges in sourcing and obtaining primary cells for research and production. Primary cells are derived directly from tissues and have a finite lifespan, making them scarce and expensive. Isolation processes can be technically demanding and may yield limited quantities of viable cells. Additionally, donor variability, ethical considerations, and stringent regulatory requirements further restrict their availability.

Opportunity:

Advancements in 3D cell culture

Advancements in 3D cell culture technology are significantly enhancing the primary cell culture market. These technologies provide more physiologically relevant models by better mimicking the in vivo environment compared to traditional 2D cultures. Innovations such as scaffold-based systems, spheroids, and organoids allow for more accurate cell-cell and cell-matrix interactions. This leads to improved disease modeling, drug screening, and tissue engineering applications. Moreover, 3D cultures support the growth of primary cells that retain their differentiated state and functionality, making them valuable for personalized medicine and regenerative therapies.

Threat:

Reproducibility and standardization issues

In the primary cell culture market, reproducibility and standardization are critical challenges. Primary cells, derived directly from tissues, exhibit inherent biological variability, leading to inconsistent experimental outcomes. Standardization issues arise due to the lack of uniform protocols and quality controls, making it difficult to ensure consistency across different labs and experiments. Such challenges can hinder the reliability of research findings, affect the development of cell-based assays, and complicate regulatory approvals.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the primary cell culture market, primarily through disruptions in supply chains and operational delays in laboratories. Increased demand for research related to SARS-CoV-2 spurred growth in the market, as primary cell cultures became crucial for studying virus behavior, developing vaccines, and testing antiviral drugs. Laboratories pivoted to COVID-19 research, which accelerated innovation and funding in cell culture technologies. However, the focus on pandemic-related studies also caused delays in non-COVID-19 research, affecting the overall research pipeline and project timelines.

The primary cells segment is expected to be the largest during the forecast period

The growth of the primary cells segment in the primary cell culture market can be attributed to several factors. There is increasing demand for more physiologically relevant cellular models for drug development and testing, which primary cells provide due to their direct extraction from tissues. This segment benefits from advancements in isolation techniques that preserve cellular integrity and function, enhancing their utility in research and clinical applications. Additionally, primary cells offer researchers the ability to study complex cellular interactions and disease mechanisms more accurately compared to immortalized cell lines.

The enzymatic degradation segment is expected to have the highest CAGR during the forecast period

Enzymatic degradation in the primary cell culture market is the process of using enzymes to dissociate cells from tissues or to degrade unwanted cellular components during cell culture. This segment's growth is driven by the increasing demand for efficient and gentle methods of cell isolation and maintenance. Enzymes such as trypsin, collagenase, and dispase are crucial in achieving high cell yields with minimal damage, thereby supporting various applications in research, drug development, and regenerative medicine. Advancements in enzyme technology, including the development of recombinant enzymes and improved formulations, further enhance the reliability and specificity of enzymatic degradation methods.

Region with largest share:

The North American region has experienced significant growth in the primary cell culture market due to several factors. First, there is increasing research and development activity in the biotechnology and pharmaceutical sectors, driving demand for primary cell culture techniques for drug discovery and development. The rising prevalence of chronic diseases and the need for personalized medicine have emphasized the importance of primary cell cultures in studying disease mechanisms and developing targeted therapies. Moreover, collaborations between academic institutions, research organizations, and industry players have contributed to the region's growth by facilitating knowledge exchange.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth in the primary cell culture market due to several factors. Increasing investments in the biotechnology and pharmaceutical industries across countries like China, India, Japan, and South Korea have driven demand. These nations are expanding their research capabilities and infrastructure, fostering a conducive environment for cell culture technologies. Additionally, the rising prevalence of chronic diseases has fuelled the need for advanced research in drug development, further boosting the market.

Key players in the market

Some of the key players in Primary Cell Culture market include American Type Culture Collection, Axol Bioscience Ltd., BioIVT, CGT Global, Corning Incorporated, Creative Bioarray, Cyagen , Danaher, Epithelix Sarl, FUJIFILM Wako Pure Chemical Corporation, HemaCare Corporation, Lonza Bioscience, Mattek, Merck KGaA, Neuromics, PPA Research Group, Inc., ReachBio LLC, STEMCELL Technologies, Thermo Fisher Scientific Inc. and XenoTech, LLC.

Key Developments:

In February 2024, BioIVT announced it has increased its capacity to deliver readily-available fresh, standard and mobilized, human leukopaks. Building on decades of human derived cell collection expertise, this additional capability enables BioIVT to further scale its world-class network of diverse, highly characterized donors and makes the company a leading provider of fresh leukopaks in the UK and mainland Europe.

In June 2024, Danaher Corporation has launched a strategic collaboration with Cincinnati Children's Hospital Medical Center, with the goal of improving patient safety by addressing a leading cause of failure in clinical trials. As part of the Danaher Beacons program, the multi-year collaboration aims to improve liver organoid technology as a drug toxicity screening solution for safeguarding patients.

Products Covered:

Primary Cells
Reagents and Supplements
Media
Other Products

Cell Types Covered:

Human Cells
Animal Cells

Separation Methods Covered:

Enzymatic Degradation
Explant Method
Mechanical Separation
Other Separation Methods

Applications Covered:

Vaccine Production
Virology
Cell & Gene Therapy Development
Model System
Stem Cell Therapy
Cancer Research
Prenatal Diagnosis
Other Applications

End Users Covered:

Academic and Research Institutions
Contract Research Organizations (CROs)
Pharmaceutical and Biotechnology Companies
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Primary Cell Culture Market, By Product

5.1 Introduction
5.2 Primary Cells
- 5.2.1 Blood Cells
- 5.2.2 Bone Cells
- 5.2.3 Endothelial Cells
- 5.2.4 Fat Cells
- 5.2.5 Muscle Cells
- 5.2.6 Nerve Cells
- 5.2.7 Skin Cells
- 5.2.8 Other Cells
5.3 Reagents and Supplements
- 5.3.1 Sera
- 5.3.2 Growth Factors and Cytokines
- 5.3.3 Buffers and Salts
- 5.3.4 Attachment Solutions
- 5.3.5 Other Reagents and Supplements
5.4 Media
5.5 Other Products

6 Global Primary Cell Culture Market, By Cell Type

6.1 Introduction
6.2 Human Cells
6.3 Animal Cells

7 Global Primary Cell Culture Market, By Separation Method

7.1 Introduction
7.2 Enzymatic Degradation
- 7.2.1 Trypsin
- 7.2.2 Protease
- 7.2.3 Pronase
- 7.2.4 Papain
- 7.2.5 Neuraminidase
- 7.2.6 Hyaluronidase
- 7.2.7 Elastase
- 7.2.8 DNase
- 7.2.9 Dispane
- 7.2.10 Collagenase
- 7.2.11 Accutase
- 7.2.12 Other Enzymatic Degradations
7.3 Explant Method
7.4 Mechanical Separation
7.5 Other Separation Methods

8 Global Primary Cell Culture Market, By Application

8.1 Introduction
8.2 Vaccine Production
8.3 Virology
8.4 Cell & Gene Therapy Development
8.5 Model System
8.6 Stem Cell Therapy
8.7 Cancer Research
8.8 Prenatal Diagnosis
8.9 Other Applications

9 Global Primary Cell Culture Market, By End User

9.1 Introduction
9.2 Academic and Research Institutions
9.3 Contract Research Organizations (CROs)
9.4 Pharmaceutical and Biotechnology Companies
9.5 Other End Users

10 Global Primary Cell Culture Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 American Type Culture Collection
12.2 Axol Bioscience Ltd.
12.3 BioIVT
12.4 CGT Global
12.5 Corning Incorporated
12.6 Creative Bioarray
12.7 Cyagen
12.8 Danaher
12.9 Epithelix Sarl
12.10 FUJIFILM Wako Pure Chemical Corporation
12.11 HemaCare Corporation
12.12 Lonza Bioscience
12.13 Mattek
12.14 Merck KGaA
12.15 Neuromics
12.16 PPA Research Group, Inc.
12.17 ReachBio LLC
12.18 STEMCELL Technologies
12.19 Thermo Fisher Scientific Inc.
12.20 XenoTech, LLC

简介目录图表

List of Tables

Table 1 Global Primary Cell Culture Market Outlook, By Region (2022-2030) ($MN)
Table 2 Global Primary Cell Culture Market Outlook, By Product (2022-2030) ($MN)
Table 3 Global Primary Cell Culture Market Outlook, By Primary Cells (2022-2030) ($MN)
Table 4 Global Primary Cell Culture Market Outlook, By Blood Cells (2022-2030) ($MN)
Table 5 Global Primary Cell Culture Market Outlook, By Bone Cells (2022-2030) ($MN)
Table 6 Global Primary Cell Culture Market Outlook, By Endothelial Cells (2022-2030) ($MN)
Table 7 Global Primary Cell Culture Market Outlook, By Fat Cells (2022-2030) ($MN)
Table 8 Global Primary Cell Culture Market Outlook, By Muscle Cells (2022-2030) ($MN)
Table 9 Global Primary Cell Culture Market Outlook, By Nerve Cells (2022-2030) ($MN)
Table 10 Global Primary Cell Culture Market Outlook, By Skin Cells (2022-2030) ($MN)
Table 11 Global Primary Cell Culture Market Outlook, By Other Cells (2022-2030) ($MN)
Table 12 Global Primary Cell Culture Market Outlook, By Reagents and Supplements (2022-2030) ($MN)
Table 13 Global Primary Cell Culture Market Outlook, By Sera (2022-2030) ($MN)
Table 14 Global Primary Cell Culture Market Outlook, By Growth Factors and Cytokines (2022-2030) ($MN)
Table 15 Global Primary Cell Culture Market Outlook, By Buffers and Salts (2022-2030) ($MN)
Table 16 Global Primary Cell Culture Market Outlook, By Attachment Solutions (2022-2030) ($MN)
Table 17 Global Primary Cell Culture Market Outlook, By Other Reagents and Supplements (2022-2030) ($MN)
Table 18 Global Primary Cell Culture Market Outlook, By Media (2022-2030) ($MN)
Table 19 Global Primary Cell Culture Market Outlook, By Other Products (2022-2030) ($MN)
Table 20 Global Primary Cell Culture Market Outlook, By Cell Type (2022-2030) ($MN)
Table 21 Global Primary Cell Culture Market Outlook, By Human Cells (2022-2030) ($MN)
Table 22 Global Primary Cell Culture Market Outlook, By Animal Cells (2022-2030) ($MN)
Table 23 Global Primary Cell Culture Market Outlook, By Separation Method (2022-2030) ($MN)
Table 24 Global Primary Cell Culture Market Outlook, By Enzymatic Degradation (2022-2030) ($MN)
Table 25 Global Primary Cell Culture Market Outlook, By Trypsin (2022-2030) ($MN)
Table 26 Global Primary Cell Culture Market Outlook, By Protease (2022-2030) ($MN)
Table 27 Global Primary Cell Culture Market Outlook, By Pronase (2022-2030) ($MN)
Table 28 Global Primary Cell Culture Market Outlook, By Papain (2022-2030) ($MN)
Table 29 Global Primary Cell Culture Market Outlook, By Neuraminidase (2022-2030) ($MN)
Table 30 Global Primary Cell Culture Market Outlook, By Hyaluronidase (2022-2030) ($MN)
Table 31 Global Primary Cell Culture Market Outlook, By Elastase (2022-2030) ($MN)
Table 32 Global Primary Cell Culture Market Outlook, By DNase (2022-2030) ($MN)
Table 33 Global Primary Cell Culture Market Outlook, By Dispane (2022-2030) ($MN)
Table 34 Global Primary Cell Culture Market Outlook, By Collagenase (2022-2030) ($MN)
Table 35 Global Primary Cell Culture Market Outlook, By Accutase (2022-2030) ($MN)
Table 36 Global Primary Cell Culture Market Outlook, By Other Enzymatic Degradations (2022-2030) ($MN)
Table 37 Global Primary Cell Culture Market Outlook, By Explant Method (2022-2030) ($MN)
Table 38 Global Primary Cell Culture Market Outlook, By Mechanical Separation (2022-2030) ($MN)
Table 39 Global Primary Cell Culture Market Outlook, By Other Separation Methods (2022-2030) ($MN)
Table 40 Global Primary Cell Culture Market Outlook, By Application (2022-2030) ($MN)
Table 41 Global Primary Cell Culture Market Outlook, By Vaccine Production (2022-2030) ($MN)
Table 42 Global Primary Cell Culture Market Outlook, By Virology (2022-2030) ($MN)
Table 43 Global Primary Cell Culture Market Outlook, By Cell & Gene Therapy Development (2022-2030) ($MN)
Table 44 Global Primary Cell Culture Market Outlook, By Model System (2022-2030) ($MN)
Table 45 Global Primary Cell Culture Market Outlook, By Stem Cell Therapy (2022-2030) ($MN)
Table 46 Global Primary Cell Culture Market Outlook, By Cancer Research (2022-2030) ($MN)
Table 47 Global Primary Cell Culture Market Outlook, By Prenatal Diagnosis (2022-2030) ($MN)
Table 48 Global Primary Cell Culture Market Outlook, By Other Applications (2022-2030) ($MN)
Table 49 Global Primary Cell Culture Market Outlook, By End User (2022-2030) ($MN)
Table 50 Global Primary Cell Culture Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
Table 51 Global Primary Cell Culture Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
Table 52 Global Primary Cell Culture Market Outlook, By Pharmaceutical and Biotechnology Companies (2022-2030) ($MN)
Table 53 Global Primary Cell Culture Market Outlook, By Other End Users (2022-2030) ($MN)